Frequent Engagement of the Classical and Alternative NF-κB Pathways by Diverse Genetic Abnormalities in Multiple MyelomaChristina M. Annunziata, Louis M. Staudt, R. Eric Davis et al.|Cancer Cell|2007Cited by 949
Activation of NF-κB Signaling by Inhibitor of NF-κB Kinase β Increases Aggressiveness of Ovarian CancerLídia Hernandez, Christina M. Annunziata|Cancer Research|2010Cited by 115
Evolutionarily conserved protein ERH controls CENP-E mRNA splicing and is required for the survival of KRAS mutant cancer cellsMeng‐Tzu Weng, Ji Luo, Marianne K. H. Kim et al.|Proceedings of the National Academy of Sciences|2012Cited by 72
IΚΚε cooperates with either MEK or non-canonical NF-kB driving growth of triple-negative breast cancer cells in different contextsCarrie D. House, Christina M. Annunziata|BMC Cancer|2018Cited by 27
Disulfiram Transcends ALDH Inhibitory Activity When Targeting Ovarian Cancer Tumor-Initiating CellsMichael W. Caminear, Christina M. Annunziata|Frontiers in Oncology|2022Cited by 24